Venous thromboEmbolism Network (VENUS)

Versiti supports the clinical coordinating center for VENUS.

About VENUS

 

Collaborative Clinical Research

The Venous thromboEmbolism Network U.S. (VENUS) is the only collaborative clinical trial research network in the U.S. focused on venous thrombosis, including venous thromboembolism (VTE) and pulmonary embolism (PE).

VENUS initiates and implements collaborative, multi-institutional clinical trials and scientific research projects. Members are individual physician-scientists employed at various academic medical or other non-commercial research institutions in the U.S. Versiti supports the clinical coordinating center for VENUS.

Versiti Coordinating Center

 
 
Thrombosis: Not All Blood Clots Are Created Equal
Associate Investigator Lisa Baumann Kreuziger, MD, MS, is researching venous blood clots.
 
Versiti to Coordinate NIH Trials of Blood Thinners to Improve Care for COVID-19 Patients at Risk for Blood Clots
Versiti to Coordinate NIH Trials of Blood Thinners to Improve Care for  COVID-19 Patients at Risk for Blood Clots 
 
Investigators Join in the Fight Against COVID-19
Versiti Blood Research Institute’s cutting-edge laboratory research will contribute to the knowledge of how to treat and prevent coronavirus.
 
Our Experts
Research investigators, postdoctoral fellows and laboratory staff at Versiti Blood Research Institute and Diagnostic Laboratories.
 
VBRI Education
Versiti Blood Research Institute researchers and staff have access to medical research seminars, fellowships, training opportunities and more.
 
Lisa Baumann Kreuziger, MD, MS
Dr. Baumann Kreuziger is a medical director of hematology and investigator at Versiti Blood Research Institute who specializes in non-malignant hematology.
 
Versiti Blood Research Institute
Versiti Blood Research Institute investigators study blood disorders like hemophilia, blood cancers like leukemia, and other blood diseases.